LLY vs PFE
By Alex · Tickerpine
Eli Lilly and Company vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | PFE |
|---|---|---|
| Price | $1,443.50 | $28.89 |
| Market cap | $1.29T | $164.67B |
| P/E ratio | 46.9 | 41.3 |
| ROE | 86.02% | 4.47% |
| Profit margin | 31.90% | 6.34% |
| Revenue growth | 38.60% | -0.40% |
| Dividend yield | 0.48% | 5.95% |
| Beta | 0.39 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs PFE in plain English
- LLY is the bigger company — about 7.8× the market cap of PFE.
- PFE is cheaper on earnings (P/E 41.3 vs 46.9).
- LLY earns a higher return on equity (86% vs 4%).
- LLY is growing revenue faster (39% vs -0%).
- PFE has the higher dividend yield (5.95% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.